The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients.

Suppr

超能文献

作者信息

ADAIR F E, MELLORS R C

出版信息

J Am Med Assoc. 1949 Aug 13;140(15):1193-1200. doi: 10.1001/jama.1949.02900500001001.

DOI:10.1001/jama.1949.02900500001001

PMID:18136181

Abstract

摘要

相似文献

The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients.

J Am Med Assoc. 1949 Aug 13;140(15):1193-1200. doi: 10.1001/jama.1949.02900500001001.

Treatment of far-advanced inoperable carcinoma of the breast with estrogens and androgens.雌激素和雄激素治疗晚期无法手术的乳腺癌

J Clin Endocrinol Metab. 1948 Jul;8(7):585.

[Hormone therapy and breast cancer].[激素疗法与乳腺癌]

J Med Lyon. 1962 Jan 20;43:139-48.

[The importance of tissue culture for hormone therapy in breast carcinoma].[组织培养在乳腺癌激素治疗中的重要性]

Klin Med Osterr Z Wiss Prakt Med. 1962 Feb;17:83-9.

Treatment of the menopause syndrome; advantages of combining oral androgens with estrogens.更年期综合征的治疗；口服雄激素与雌激素联合使用的优势。

Ann West Med Surg. 1949 May;3(5):186.

On the influence of androgen and estrogen administration on chemically induced albino rat sarcoma.雄激素和雌激素给药对化学诱导的白化大鼠肉瘤的影响

Ann Med Exp Biol Fenn. 1947;25(1):5-23.

[Hormonal treatment of cancer of the breast].[乳腺癌的激素治疗]

Dia Med. 1961 Oct 9;33:2322-8.

Treatment of postmenopausal osteoporosis with oestrogens and androgens.雌激素和雄激素治疗绝经后骨质疏松症

Acta Endocrinol (Copenh). 1960 May;34:51-9. doi: 10.1530/acta.0.xxxiv0051.

Treatment of advanced mammary cancer with testosterone.用睾酮治疗晚期乳腺癌。

J Am Med Assoc. 1948 Sep 18;138(3):187-90. doi: 10.1001/jama.1948.02900030019004.

The use of protein anabolizers.蛋白质合成代谢促进剂的使用。

Br J Clin Pract. 1959 Aug;13:541-5.

引用本文的文献

Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches.重新审视雌激素治疗内分泌抵抗性乳腺癌：新型治疗方法

Cancers (Basel). 2023 Jul 17;15(14):3647. doi: 10.3390/cancers15143647.

Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites.

Endocrine. 1995 Sep;3(9):661-5. doi: 10.1007/BF02746342.

General medical aspects of malignant disease.恶性疾病的一般医学方面。

Postgrad Med J. 1961 Jun;37(428):305-15. doi: 10.1136/pgmj.37.428.305.

Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate.

Breast Cancer Res Treat. 1992;24(2):127-37. doi: 10.1007/BF01961245.

Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.控释低剂量醋酸甲羟孕酮（MPA）可抑制大鼠中由二甲基苯并(a)蒽诱导的乳腺肿瘤的发展。

Breast Cancer Res Treat. 1993;26(3):253-65. doi: 10.1007/BF00665803.

Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.脱氢表雄酮对7,12-二甲基苯并(a)蒽（DMBA）诱导的大鼠乳腺癌发生的预防作用。

Breast Cancer Res Treat. 1994 Feb;29(2):203-17. doi: 10.1007/BF00665681.

Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity.

Breast Cancer Res Treat. 1991 Aug;18(3):141-8. doi: 10.1007/BF01990029.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验